跳到主要导航
跳到搜索
跳到主要内容
北京理工大学 首页
English
中文
首页
师资队伍
研究单位
科研成果
奖项
按专业知识、名称或附属进行搜索
查看 Scopus 资料
解 炳腾
生命学院
h-index
421
引用
11
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
2018
2024
每年的科研成果
概览
指纹图谱
合作网络
科研成果
(29)
指纹图谱
深入其中 Bingteng Jie 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Material Science
Amino Acids
8%
Biosensor
54%
Carbon Nanotube
11%
Cobalt
25%
Electrochemical Aptasensor
25%
Electrochemical Sensor
75%
Electropolymerization
11%
Enantiomer
50%
Energy Levels
12%
Film
11%
Glassy Carbon
15%
Hydrothermal Synthesis
8%
Interferon
25%
Ionic Liquid
50%
Metal-Organic Framework
100%
MXene
25%
Nanocomposites
8%
Sensitive Detection
50%
Silicon
25%
Single Crystal
16%
Surface (Surface Science)
25%
Synthetic Polymer
25%
Tumor
25%
Voltammetry
46%
Wet Etching
25%
Biochemistry, Genetics and Molecular Biology
Adaptive Immunity
6%
Adenosine Diphosphate Ribose
25%
ADP-ribosylation
25%
Aptamer
12%
BARD1
25%
Biogenesis
5%
Biomimetics
25%
Blastocyst
6%
Bovine Somatotropin
25%
BRCA1 Protein
25%
BRCA2
25%
Centrosome
25%
Chromosome Instability
6%
Chromosome Segregation
25%
Cisplatin
25%
CXCR7
6%
Cyclic Adenosine Monophosphate
25%
DNA Damage Response
12%
DNA Repair Protein
6%
Ectopic Expression
6%
Enzyme
5%
F-Box Protein
18%
Folliculogenesis
12%
Gamete
6%
Growth Hormone
25%
Histone H3
6%
Human Cell Culture
6%
In Vitro Maturation
25%
Innate Immunity
12%
Metaphase
6%
MicroRNA
25%
Molecular Imprinting
25%
Optics
12%
P53
9%
Pericentriolar Material
25%
Poly ADP Ribose Polymerase
9%
Pseudouridine
15%
Rad50
6%
Retinoic Acid
6%
RNA
5%
Sensor Technology
12%
Signal Processing
12%
Spindle Checkpoint
6%
Surface Property
12%
Synthase
10%
TLR3
6%
Toll-Like Receptor
6%
Transfer RNA
25%
Translation Elongation
12%
Women's Health
6%
Medicine and Dentistry
Adaptive Immunity
6%
Adenosine Phosphate
6%
Blastocyst
6%
BRCA1
14%
BRCA2
25%
Centrosome
25%
DNA Damage
25%
DNA Damage Response
12%
DNA Dependent Protein Kinase
6%
DNA Repair
25%
Double Strand Break Repair Protein MRE11
6%
Growth Hormone
25%
In Vitro Maturation
25%
Innate Immunity
12%
Malate Dehydrogenase (Decarboxylating)
25%
Molecularly Targeted Therapy
25%
Nodular Melanoma
6%
Oocyte
25%
Ovary Follicle Development
5%
PARP Inhibitor
25%
Poly(adenosine Diphosphate Ribose)
25%
Primary Ovarian Insufficiency
25%
Synthetase
6%
Toll Like Receptor 3
6%
Toll Like Receptor 9
6%
Tretinoin
6%
